HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sung-Hye Park Selected Research

Subependymal Glioma (Subependymoma)

3/2018Spinal Cord Subependymoma Surgery : A Multi-Institutional Experience.
8/2005Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sung-Hye Park Research Topics

Disease

84Neoplasms (Cancer)
08/2022 - 03/2002
43Glioblastoma (Glioblastoma Multiforme)
12/2021 - 05/2005
22Glioma (Gliomas)
01/2022 - 11/2003
13Brain Neoplasms (Brain Tumor)
01/2022 - 01/2008
10Meningioma (Meningiomas)
01/2022 - 07/2006
8Medulloblastoma
01/2018 - 05/2005
7Oligodendroglioma
01/2022 - 02/2008
5Muscular Diseases (Myopathy)
06/2021 - 08/2005
5Parkinson Disease (Parkinson's Disease)
02/2021 - 11/2017
5Disease Progression
04/2020 - 02/2009
5Astrocytoma (Pilocytic Astrocytoma)
04/2020 - 08/2005
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2021
4Lymphoma (Lymphomas)
01/2022 - 10/2013
4Ependymoma
05/2021 - 04/2016
4Carcinogenesis
04/2021 - 03/2002
4Neurocytoma
04/2013 - 08/2005
3Hemangiopericytoma
01/2022 - 12/2016
3Choroid Plexus Papilloma
04/2016 - 07/2011
3Neoplasm Metastasis (Metastasis)
11/2015 - 12/2008
3Infarction (Infarctions)
11/2014 - 06/2007
2Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2022 - 08/2005
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 02/2006
2Leukocytosis (Pleocytosis)
01/2022 - 09/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2021 - 01/2021
2Central Core Myopathy (Central Core Disease)
06/2021 - 12/2014
2Myositis (Idiopathic Inflammatory Myopathies)
06/2021 - 06/2014
2Parkinsonian Disorders (Parkinsonism)
04/2021 - 12/2020
2Cysts
01/2021 - 10/2013
2Synucleinopathies
11/2020 - 11/2017
2Neurologic Manifestations (Neurological Manifestations)
06/2020 - 04/2018
2Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2019 - 11/2017
2Neuroepithelial Neoplasms (Gliomatosis Cerebri)
12/2018 - 05/2010
2Respiratory Insufficiency (Respiratory Failure)
05/2018 - 01/2018
2Subependymal Glioma (Subependymoma)
03/2018 - 08/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
08/2017 - 05/2008
2Retinoblastoma (Glioblastoma, Retinal)
05/2015 - 09/2012
2Melanoma (Melanoma, Malignant)
02/2015 - 10/2006
2Adenoma (Adenomas)
03/2014 - 09/2007
2Pituitary Neoplasms (Pituitary Adenoma)
03/2014 - 09/2007
2Ganglioglioma
12/2011 - 05/2010

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
10/2021 - 08/2005
17Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 07/2011
15Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2008
13Biological ProductsIBA
08/2022 - 03/2005
11Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2021 - 11/2012
10MethyltransferasesIBA
01/2019 - 08/2009
10DNA (Deoxyribonucleic Acid)IBA
01/2019 - 10/2006
8VimentinIBA
10/2021 - 11/2003
8Mucin-1 (CA 15-3 Antigen)IBA
12/2018 - 11/2003
7Glial Fibrillary Acidic ProteinIBA
12/2018 - 11/2003
5NestinIBA
09/2020 - 08/2005
5S100 Proteins (S 100 Protein)IBA
09/2020 - 11/2003
5SynaptophysinIBA
01/2019 - 05/2005
5AcidsIBA
01/2017 - 10/2009
4RNA (Ribonucleic Acid)IBA
01/2022 - 05/2018
4EnzymesIBA
06/2021 - 06/2010
4SynucleinsIBA
02/2021 - 06/2017
4AntigensIBA
06/2020 - 11/2003
4O-(6)-methylguanineIBA
01/2019 - 02/2011
3Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
06/2021 - 02/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 03/2015
3alpha-SynucleinIBA
12/2020 - 11/2017
3ErbB Receptors (EGF Receptor)IBA
03/2014 - 01/2013
2Myelin-Oligodendrocyte GlycoproteinIBA
01/2022 - 06/2020
2Immunoglobulin G (IgG)IBA
01/2022 - 06/2020
2Anaplastic Lymphoma KinaseIBA
01/2022 - 03/2005
2N 30IBA
12/2021 - 03/2021
2CalciumIBA
06/2021 - 02/2010
2Protons (Proton)IBA
05/2021 - 10/2020
2GadoliniumIBA
01/2021 - 09/2012
2Tumor Biomarkers (Tumor Markers)IBA
10/2020 - 01/2008
2Oligodendrocyte Transcription Factor 2IBA
12/2018 - 04/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2018 - 04/2010
2Contrast MediaIBA
01/2018 - 03/2015
2Branched-Chain Amino AcidsIBA
12/2017 - 10/2016
2Messenger RNA (mRNA)IBA
12/2017 - 06/2010
2SurvivinIBA
08/2017 - 03/2002
2Disulfiram (Antabuse)FDA Link
08/2017 - 06/2015
2Telomerase (Telomerase Reverse Transcriptase)IBA
05/2017 - 01/2017
2Bevacizumab (Avastin)FDA Link
10/2016 - 05/2013
2N-acetoacetyl-N-deacetylcolchicineIBA
10/2016 - 01/2014
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
04/2016 - 02/2014
2Alkylating AgentsIBA
03/2015 - 02/2011
2A-Form DNA (A-DNA)IBA
03/2015 - 02/2011
2Therapeutic UsesIBA
06/2014 - 06/2007
2TensinsIBA
03/2014 - 01/2013
2ProlactinIBA
03/2014 - 09/2007
2Small Interfering RNA (siRNA)IBA
01/2014 - 06/2013
2Codon (Codons)IBA
11/2012 - 05/2005

Therapy/Procedure

27Radiotherapy
01/2022 - 05/2005
15Drug Therapy (Chemotherapy)
10/2022 - 02/2006
12Therapeutics
10/2021 - 12/2005
9Chemoradiotherapy
01/2020 - 02/2011
5Adjuvant Radiotherapy
01/2022 - 11/2013
3Stem Cell Transplantation
12/2019 - 06/2007
3Aftercare (After-Treatment)
01/2018 - 05/2005
2Immunotherapy
01/2022 - 09/2018
2Combined Modality Therapy
01/2021 - 03/2013
2Craniotomy
11/2014 - 05/2008
2Ligation
02/2013 - 10/2012